Aligos Therapeutics (ALGS) EBIT Margin Growth (5y) (2026)

Aligos Therapeutics (ALGS) EBIT Margin Growth (5y) (2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.89 Bn	131.04 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.05 Bn	78.06 Bn	3.93 Bn
3	Argenx Se	65.56 Bn	60.38 Bn	1.37 Bn
4	Moderna	55.46 Bn	50.32 Bn	52.00 Mn
5	BeOne Medicines	42.12 Bn	37.02 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn
7	BioNTech SE	27.70 Bn	9.30 Bn	668.28 Mn
8	Insmed	27.51 Bn	26.35 Bn	358.27 Mn
9	Royalty Pharma	27.38 Bn	26.54 Bn	-
10	Aligos Therapeutics	70.20 Mn	39.76 Mn	-

Download Data

Date	Value
Mar 31, 2026	209,680.00